Our stand had representatives from our HR, marketing, software, project management and algorithm teams and it was great to see it so busy across both days.
It was a great opportunity to speak to people about the ground-breaking work we do at B-Secur and about how our company is in full scale-up mode with opportunities across many of our departments.
With the launch of our HeartKey® 2.0 technology and the expansion of our teams both in the U.S. and in Belfast, 2022 has been a landmark year for our company. We were delighted to be able to share our story with other tech companies from Northern Ireland who were all on different stages of their growth journey.
There are so many companies here who are doing amazing work which deserves to be recognised on the global stage and being part of communities such as Digital DNA is an excellent way for us all to support one another.
“As first time exhibitors at Digital DNA the event surpassed our expectations. A superb networking event, which had everything you could want from engaging speakers and panel discussions to a tech exhibition with a range of start ups and large tech employers. It really was the best of the best from the local NI tech scene. We were very proud to showcase our HeartKey 2.0 technology with our VR demo and share our growth journey as a NI business. We met lots of new local businesses and spoke to students keen to start their tech journey. Thank you Digital DNA for a fantastic event.” – Caroline Murdoch, People Director
We are confident the work we are doing to help people take control of their heart health has the power to truly transform the remote monitoring landscape.
Our cloud based HeartKey® 2.0 technology, which was launched earlier this year in San Francisco, elevates EKG interpretation to new heights of efficiency and accuracy as well as offering a range of FDA-cleared health algorithms and actionable wellness insights.
With a convergence taking place within the consumer and medical device industries our software is strategically placed at centre of both sectors, meaning it can used in both next generation wearables and the latest medical devices.